Retail theft in the U.S. is reaching critical levels, costing businesses around $100 billion annually. While shoplifting and various forms of employee theft are rising, a particularly challenging issue is "sweethearting."

By David Burns, freelance writer.

Radio frequency identification (RFID) is an identification system that works through radio frequencies that can track and identify authorised entry tools such as fobs and key cards. Not only is RFID a significant security measure, but it also provides your team with a reliable and efficient method of access.

Ukraine dreamed of becoming "the key to the security of Europe's gas supply,” the gas hub of Europe. Moscow found this unnecessary. Ukraine wants to become EU's gas hub According to Deputy Minister of Energy of Ukraine Svetlana Grinchuk, imports usually account for up to 10 billion cubic meters of the total volume of Ukrainian storage facilities of 31 billion cubic meters. Ukraine stores gas from Poland, Norway, Hungary, and other countries, which they receive even from the Caspian region, as well as liquefied natural gas (LNG), which comes to Europe from the United States. "The EU aims to phase out the use of Russian gas and reduce the share of fossil fuels in the energy mix. Ukraine can help achieve these goals," Grinchuk told Euractiv.

[Domestic] :
Memorial events are taking place across the country to honor the victims of the Itaewon crowd crush on Tuesday, the second anniversary of the tragedy.  Earlier in the day, a memorial event at the National Assembly brought together survivors, members of the bereaved families, the National Assembly ...

[more...]

[Economy] :
Global investment banks have slashed their growth outlook for South Korea for this year. According to the Korea Center for International Finance on Friday, the growth forecast by eight foreign investment banks averaged two-point-three percent at the end of October, representing a zero-point-two percentage ...

[more...]

BGS updates national CO2 storage database  Agg-Net

Funding awarded for study on hydrogen storage potential in the East Midlands  British Geological Survey

Algebraic expressions for averaging linear and nonlinear stiffness tensors from general anisotropy to different effective symmetries (11 Laue classes elastically representing all 32 crystal classes, and two non-crystalline symmetries: isotropic and cylindrical) have been derived by automatic symbolic computations of the arithmetic mean over the set of rotational transforms determining a given symmetry. This approach generalizes the Voigt average to nonlinear constants and desired approximate symmetries other than isotropic, which can be useful for a description of textured polycrystals and rocks preserving some symmetry aspects. Low-symmetry averages have been used to derive averages of higher symmetry to speed up computations. Relationships between the elastic constants of each symmetry have been deduced from their corresponding averages by resolving the rank-deficient system of linear equations. Isotropy has also been considered in terms of generalized Lamé constants. The results are published in the form of appendices in the supporting information for this article and have been deposited in the Mendeley database.

Fourth-generation synchrotron storage rings represent a significant milestone in synchrotron technology, offering outstandingly bright and tightly focused X-ray beams for a wide range of scientific applications. However, due to their inherently tight magnetic lattices, these storage rings have posed critical challenges for accessing lower-energy radiation, such as infrared (IR) and THz. Here the first-ever IR beamline to be installed and to operate at a fourth-generation synchrotron storage ring is introduced. This work encompasses several notable advancements, including a thorough examination of the new IR source at Sirius, a detailed description of the radiation extraction scheme, and the successful validation of our optical concept through both measurements and simulations. This optimal optical setup has enabled us to achieve an exceptionally wide frequency range for our nanospectroscopy experiments. Through the utilization of synchrotron IR nanospectroscopy on biological and hard matter samples, the practicality and effectiveness of this beamline has been successfully demonstrated. The advantages of fourth-generation synchrotron IR sources, which can now operate with unparalleled stability as a result of the stringent requirements for producing low-emittance X-rays, are emphasized.

A multi-objective genetic algorithm (MOGA) is a powerful global optimization tool, but its results are considerably affected by the crossover parameter ηc. Finding an appropriate ηc demands too much computing time because MOGA needs be run several times in order to find a good ηc. In this paper, a self-adaptive crossover parameter is introduced in a strategy to adopt a new ηc for every generation while running MOGA. This new scheme has also been adopted for a multi-generation Gaussian process optimization (MGGPO) when producing trial solutions. Compared with the existing MGGPO and MOGA, the MGGPO and MOGA with the new strategy show better performance in nonlinear optimization for the design of low-emittance storage rings.

The advent of diffraction-limited storage rings (DLSRs) has boosted the brilliance or coherent flux by one to two orders of magnitude with respect to the previous generation. One consequence of this brilliance enhancement is an increase in the flux density or number of photons per unit of area and time, which opens new possibilities for the spatiotemporal resolution of X-ray imaging techniques. This paper studies the time-resolved microscopy capabilities of such facilities by benchmarking the ForMAX beamline at the MAX IV storage ring. It is demonstrated that this enhanced flux density using a single harmonic of the source allows micrometre-resolution time-resolved imaging at 2000 tomograms per second and 1.1 MHz 2D acquisition rates using the full dynamic range of the detector system.

A procedure is presented to exactly obtain the apparent average crystallite size (ACS) of powder samples using standard in-house powder diffraction experiments without any restriction originating from the Scherrer equation. Additionally, the crystallite size distribution within the sample can be evaluated. To achieve this, powder diffractograms are background corrected and long-range radial distribution functions G(r) up to 300 nm are calculated from the diffraction data. The envelope function fenv of G(r) is approximated by a procedure determining the absolute maxima of G(r) in a certain interval (r range). Fitting of an ACS distribution envelope function to this approximation gives the ACS and its distribution. The method is tested on diffractograms of LaB6 standard reference materials measured with different wavelengths to demonstrate the validity of the approach and to clarify the influence of the wavelength used. The latter results in a general description of the maximum observable average crystallite size, which depends on the instrument and wavelength used. The crystallite site distribution is compared with particle size distributions based on transmission electron microscopy investigations, providing an approximation of the average number of crystallites per particle.

When a promising new drug to treat obesity was approved by the Food and Drug Administration for sale in the U.S. last month, it was the first such treatment to gain approval since 2014.

In clinical trials, weekly injections of semaglutide — or Wegovy, as it's been branded -- helped people drop an average of 15% of their body weight. That's an average of about 34 pounds over 16 months, before their weight plateaued, a far greater weight loss, obesity specialists say, than achieved with other drugs on the market. At least as important, Wegovy raised none of the alarm bells with the FDA or obesity doctors that it might trigger serious side effects of the sort experienced by some people taking fen-phen or some previous medical treatments for obesity.

But with a price tag for Wegovy of $1,000 to $1,500 a month, a very big question remains: Will insurers cover its significant cost for the many millions of people like Marleen Greenleaf, who might benefit?

Greenleaf grew up on the island of Trinidad, where her entire family paid little heed to what they ate and paid a high medical price, she says: "My husband has diabetes, my sister has diabetes, my brother has diabetes."

Since then, she's tried — and failed — at numerous diets, says Greenleaf, now 58 and an administrator at a charter school in Washington, D.C. Then, in 2018, she signed up for the clinical trial of a new drug — a once-weekly shot that changes the way her brain signals hunger.

A drug that finally stops her cravings

She noticed the change soon after her first injection of Wegovy: "For me, there was something that triggered in my brain to tell me that I was not hungry," she says. No more fierce cravings for the chocolate chip cookies she adores. Without the cravings she was able to slow down and reconsider the foods she'd been reaching for.

"I also wanted to eat healthier," she says. "I was looking at options, reading labels, looking at the calories — not just the calories, but also the sugar."

Over the 68-week research trial, Greenleaf dropped 40 pounds. Her blood pressure fell, which meant she qualified to donate her kidney to her husband, who was on dialysis.

"It was one of the best gifts of life that I could have ever given," she says.

But after that study ended, Greenleaf regained some of the weight. Wegovy is considered a long-term, possibly lifelong medication to treat chronic obesity. In the pre-marketing clinical studies, weight loss topped out at a total average weight loss of 15-18%, even as people continued to take the drug. And, as was the case with Greenleaf, once they stopped getting the weekly injections some of that weight came back.

Now, Greenleaf wants to resume the Wegovy shots.

"My only challenge actually is getting the insurance company to approve it," she says.

Reimbursement for obesity drugs' cost is patchy

Insurance coverage, it turns out, is a giant question — not just with Wegovy, but with obesity drugs in general. Some private insurers do include some prescription obesity drugs in the list of medicines they'll cover; it's too early to tell whether Wegovy will make those lists. Many doctors and patients are optimistic, because it is a higher dose of an existing diabetes medication called Ozempic, which is often covered by insurers.

A few select state Medicaid programs will cover medications that treat obesity, in some circumstances. But, significantly, Medicare does not cover obesity drugs — and many private insurers typically follow Medicare's lead.

Yet the demand for a good treatment is there, says Dr. Fatima Cody Stanford, a leading obesity researcher at Harvard. She was not involved in conducting the Wegovy clinical trial, but closely followed it. "I'm excited about it," she says, because of the dramatic weight loss.

The drug acts on the brain so people eat less and store less of what they eat. That helps address the excess weight as well as helping with numerous related diseases of the liver or heart, for example.

Why the FDA has been slow to approve obesity treatments

There is a long history of drugs that have looked like promising treatments for obesity, then failed. Decades ago, amphetamines, were prescribed, until their addictive properties became apparent. In the 1990s, the combination of fenfluramine and phentermine — administered as the diet drug fen-phen — was heavily marketed, only to later be pulled from the market for causing heart valve problems.

Those experiences and others have made physicians skeptical.

"In obesity medicine field, we've learned to be cautiously optimistic each time we have a new medication that looks promising," says Dr. Ihuoma Eneli, director of the Center for Healthy Weight and Nutrition at Nationwide Children's Hospital in Columbus, Ohio, who was not involved in the study of Wegovy.

So far, Eneli does not see any obvious concerns with the class of drugs that includes Wegovy, and calls the results so far "very promising." Wegovy is similar to another drug made by Novo Nordisk — Saxenda — which has been on the market since 2014, and which Eneli occasionally prescribes to her pediatric patients who are struggling with obesity.

In clinical research studies, the primary side effects reported after taking Wegovy affected the digestive system: nausea, diarrhea, vomiting, constipation, abdominal pain or intestinal infections.

Eneli says such side effects and their frequency are milder than the problems that have arisen in the past. That good safety profile may mean the drug is "less likely to come up with unanticipated risks," she says.

But, the new drug will be of little use, she and other doctors who treat obesity say, if it's not also affordable for patients.

"Before I even bring up that drug with my patients, I'm looking to see which insurance they are having on the left side of my screen — because that will determine whether I bring it up," Stanford, the Harvard physician, says. "If it's out of reach, like I said, I won't bring it up."

Stanford says her patients on existing obesity medications do extraordinary things to keep their coverage so they can afford to stay on the drugs.

"Several nurses here at the hospital that are my patients stayed working — they were supposed to retire — so they could stay on their injectable medication," Stanford says,"because that's how beneficial it was to them."

Why some are willing to pay out of pocket

Some people, like David Scheesley, 42, says he would consider paying for Wegovy, even if he had to pay the full sticker price. The Hanford, Calif., correctional officer has tried since 2019 to lose weight on various diets — low-fat, all-meat, all-vegetable — without success. His weight has led to other health concerns — with his blood fats and his heart — which makes Scheesley think of his 5-year-old son.

"I want to see him for a lot of years; I don't want to have a stroke," he says. "I don't want to have diabetes. I want to be there for him. So, for me personally, that [monetary cost] is not astronomical, if it can give me some more time."

Novo Nordisk, the company that makes Wegovy, is in talks with insurers, and acknowledges that ensuring health insurance coverage of its drug is critical. The challenge, says Douglas Langa, executive vice president of Novo Nordisk North America, is getting doctors, patients, and politicians to recognize obesity as a disease — and that therefore insurance should cover the cost of medicine to treat it.

"There's a medical component to [obesity] that needs to be recognized; this is a disease state like we should be treating any other disease state," Langa says. He says about 40% of private insurers cover Saxenda, the similar weight-loss medication the company makes.

Langa tells insurance companies this, making the case for why prescriptions for Wegovy should be covered. His company is also heavily lobbying Congress to pass legislation to allow Medicare to cover obesity medications. It makes sense from a financial perspective, he argues, because obesity is the root disease underlying so many other diseases.

"We do believe insurers understand that [untreated obesity] is a gateway into 60 other health conditions," Langa says. The need is hard to ignore, he adds. More than 100 million people in the U.S. alone struggle with obesity.

This content is from Southern California Public Radio. View the original story at SCPR.org.

When it comes to air quality, many believe it's only an issue during the summer. Air quality remains a problem year round, with ozone being a concern in the summer and particulate matter posing a problem year round. Public Health is working with local officials to raise the importance of air quality awareness and what citizens can do to help improve air quality.

The explosive growth of information technology is having a profound impact on our lives.

Racial and ethnic minorities tend to receive lower-quality health care than whites do, even when insurance status, income, age, and severity of conditions are comparable.

Good morning. I am Richard Bonnie, chair of the Committee on Developing a Strategy to Reduce and Prevent Underage Drinking.

Over the next five years, the U.S. Department of Defense’s Biological Threat Reduction Program (BTRP) should encourage and be among co-leaders in the federal government’s development of an enduring interagency mechanism to address an array of biological threats – including natural disease outbreaks, accidental releases, and intentional attacks -- to deployed U.S. forces and to the nation itself, says a new report from the National Academies of Sciences, Engineering, and Medicine

Federal agencies, including the National Science Foundation (NSF), the U.S. Department of Energy (DOE), the Office of Naval Research (ONR), and Air Force Office of Scientific Research (AFOSR), should better coordinate their activities in plasma science research if the United States is to remain a leader in plasma science and engineering (PSE), says a new decadal report from the National Academies of Sciences, Engineering, and Medicine.

A new rapid expert consultation from the National Academies of Sciences, Engineering, and Medicine’s Societal Experts Action Network says strategies such as giving advance notice, partnering with trusted sources, and offering incentives can encourage individuals who have tested positive for COVID-19 to respond to health department contact tracing and share information about people they may have exposed to the virus.

Decision-makers leading COVID-19 vaccine rollouts need to begin communicating with the public immediately if they have not already — emphasizing public support for vaccinations, leveraging celebrity and community champion endorsements, and focusing on those who are skeptical or hesitant of the vaccines rather than firmly opposed — to ensure demand and promote uptake, says a new rapid expert consultation from the National Academies of Sciences, Engineering, and Medicine.

Nursing in the next 10 years will demand a larger, more diversified workforce prepared to provide care in different settings, to address the lasting effects of COVID-19, to break down structural racism and the root causes of poor health, and to respond to future public health emergencies, says a new report from the National Academy of Medicine.

Scientific thinking and knowledge are essential to democracy and the workforce, but science education is not the national priority it needs to be. The White House, with leadership from OSTP, should encourage federal agencies, state and local governments, and others to focus resources on increasing the quality and accessibility of science education.

When communicating with parents about getting their children vaccinated against COVID-19, emphasize the safety and efficacy of the vaccines, encourage them to talk with their family doctor, and leverage parents’ social networks.

Rapid advances in small satellite technology and associated launch and production capabilities have transformed the space industry. A new report recommends ways the government can partner with commercial entities to enhance national missions and make transformative science advancements.

French food services & facilities management company Sodexo is consolidating its multiple ERP installations across the group to a single cloud-based ERP platform.

Procter & Gamble (P&G) is using advanced data science algorithms to help over 20 lakh kirana stores in the country through a special initiative called ‘Smart Basket’

The biggest gaps lie in technology readiness, with only 9 per cent of companies possessing the necessary AI capabilities like machine learning frameworks, prebuilt algorithms, and dynamic compute.

Over a third of Indonesia's population do not have access to the web, especially in far-flung areas of the world's fourth most populous country.

A recent Gartner study offers some useful guidelines on how to choose an enterprise-level cloud storage provider. But don’t forget that providers need to work together effectively too.

India is leading in Artificial Intelligence (AI) adoption, according to new research by Boston Consulting Group (BCG), which pegged that 30 per cent of Indian companies are maximizing value through the use of such emerging technology.

A new service developed at Binghamton University, State University of New York could improve performance of mobile devices that save data to the cloud.

read more

Confluent chief Jay Kreps says compliance can be challenging and lead to scrutiny of data movements. “Streaming technology enables the real-time synchronization of data, connecting all these disparate sources. An apt analogy is that of a central nervous system. The capability to unify data streams from different organizational segments empowers better decision making and the creation of personalized customer experiences,” he said.

Fintech applications have simplified purchasing and put financial independence at everyone’s fingertips, challenging the traditional banking and lending system.

In an interview with ETCIO, Ravi Vijayaraghavan, SVP & Chief Data & Analytics Officer, Flipkart shares how the homegrown e-commerce giant leverages data science to drive customer experience and seller profitability.

The private-label line features a range of nutritious yet tempting snack options.

Company commits to not engage in advertising primarily directed to children under age 13.

EnWave Corp. announced that it has signed an Equipment Purchase Agreement with Dole Worldwide Food & Beverage Group to supply a 120kW Radiant Energy Vacuum dehydration processing line that will materially increase Dole’s vacuum-microwave processing capabilities.

Sweegen’s footprint in Europe became stronger after the European Union Commission published its approval of Sweegen’s non-GMO Signature Bestevia Rebaudioside M (Reb M) for use in food and beverages.

CitruSweet, ThauSweet bring lingering sweetness without the need to mask afternotes.

NFPA 70 provides the important details for design.

The 2021 USHGC is scheduled to be published in early 2021.

Whether new or retrofit construction, parking structures and shipping and loading bays are often crucial to the viability and efficient use of residential, commercial, industrial and multi-use developments. 

Hydronic-based heating and cooling systems stand ready to offer plenty of design and performance benefits. One of them is the potential for thermal storage.

Joseph Cariola, a licensed plumber and operations manager at Feddon Mechanical, converted his garage into an in-law suite with a bedroom and bathroom to accommodate up to three people.

Time savings, cleanliness and ease of installation — there were many advantages to CRW Mechanical’s use of Viega MegaPressG recently on a large project in Virginia.

From wearable safety devices to machine learning to Big Data, companies now have more tools than ever to help push safety incidents down to zero.

This strategy increases the value of each square foot with customizable racks, but do the pros outweigh the cons?

With plant-based ingredients in high demand, formulators oftentimes are turning to hydrocolloid solutions to deliver the stabilization these beverages need.